Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.
To the Editor: Because all the authors were not granted access to the raw data and the raw data could not be made available to a third-party auditor, we are unable to validate the primary data sources underlying our article, “Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19.”1 We therefore request that the article be retracted. We apologize to the editors and to readers of the Journal for the difficulties that this has caused.
Notes
This letter was published on June 4, 2020, at NEJM.org.
Disclosure forms provided by the authors are available with the full text of this letter at NEJM.org.
Supplementary Material
Disclosure Forms (nejmc2021225_disclosures.pdf)
- Download
- 191.25 KB
Reference
1.
Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular disease, drug therapy, and mortality in Covid-19. N Engl J Med 2020;382:e102-e102.
Information & Authors
Information
Published In
Copyright
Copyright © 2020 Massachusetts Medical Society. All rights reserved.
History
Published online: June 4, 2020
Published in issue: June 25, 2020
Authors
Affiliations
1Brigham and Women’s Hospital Heart and Vascular Center, Boston, MA
[email protected]
[email protected]
2Surgisphere, Chicago, IL
3Baylor College of Medicine, Houston, TX
4Christ Hospital, Cincinnati, OH
5University of Utah, Salt Lake City, UT
Metrics & Citations
Metrics
Altmetrics
Citations
Export citation
Select the format you want to export the citation of this publication.
Cited by
- Hipertensión arterial sistémica posterior a COVID-19., Revista de la Asociación Dental Mexicana, 81, 1, (11-15), (2024).https://doi.org/10.35366/114741
- Should Researchers Destroy Audio or Video Recordings?, Ethics & Human Research, 46, 2, (30-35), (2024).https://doi.org/10.1002/eahr.500205
- Open Questions over the COVID-19 Pandemic, Science, Art and Religion, 1, 2-4, (210-220), (2023).https://doi.org/10.5005/jp-journals-11005-0027
- Impacto da COVID-19 nos Programas de Reabilitação Cardiovascular no Brasil: Um Estudo Transversal Baseado em uma Pesquisa Online, Arquivos Brasileiros de Cardiologia, 120, 3, (2023).https://doi.org/10.36660/abc.20220135
- Coagulopathy in cardiac surgery in the context of the COVID-19 pandemic: A review, Consilium Medicum, 25, 1, (58-62), (2023).https://doi.org/10.26442/20751753.2023.1.202175
- Thromboembolism in COVID-19: the unsolved problem, Panminerva Medica, 65, 1, (2023).https://doi.org/10.23736/S0031-0808.20.03999-3
- Role of comorbidities on the mortality in patients with SARS-CoV-2 infection: an Italian cohort study, Minerva Medica, 114, 2, (2023).https://doi.org/10.23736/S0026-4806.21.07187-1
- A Road Map for Peer Review of Real-World Evidence Studies on Safety and Effectiveness of Treatments, Diabetes Care, 46, 8, (1448-1454), (2023).https://doi.org/10.2337/dc22-2037
- Medical treatment of patients with cardiovascular diseases during the first year after hospitalization for COVID-19, Cardiovascular Therapy and Prevention, 21, 12, (3467), (2023).https://doi.org/10.15829/1728-8800-2022-3467
- Analysis of Country-Level Risk Factors of COVID-19 Mortality Across Countries of Asia: A Generalised Estimating Equation Approach, Journal of Health Management, 25, 4, (1018-1028), (2023).https://doi.org/10.1177/09720634221150866
- See more
Loading...